InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,383.86
(
0.81%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

barefootrunner

Send PM Follow Ignore
Followers 303
Posts 4680
Boards Moderated 0
Alias Born 11/26/2009

barefootrunner

Re: None

Thursday, 12/01/2011 7:42:57 AM

Thursday, December 01, 2011 7:42:57 AM

Post# of 97239
INCY - Incyte shares significantly undervalued, says Oppenheimer
After conducting a survey of 25 U.S. oncologists/hematologists, Oppenheimer thinks that Incyte's Jakafi for myelofibrosis can meet the firm's estimate of $79M in sales for 2012. The firm maintains an Outperform rating on the stock

Visit us at the $heff $tation

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up